< %=imgalt%>
US Elections Calendar ~ Pervez Musharraf ~ Iftikhar Muhammad Chaudhry ~ Other International News
Home / International News / Press Releases / October 06, 2008
Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
magnetic resonance imaging

Cocaine addicts have abnormalities in brains cerebral cortex

Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm

Brain signals remain active even in dreamless sleep

Why teenagers squirm when dads hit the dance floor

More on magnetic resonance imaging

Top News

Praja Rajyam Party tour programme announced

BSF-Pakistan rangers meet in Lahore to combat rise in militant activities

McCain saw White House from a cell in Hanoi

Everything you ever wanted to know about sex but were afraid to ask

Sify Technologies wins brandon hall excellence in learning award for third consecutive year

Tendulkar, Team India to bat for children health and safety on Oct. 15

Worlds tiniest walking robot unveiled in Japan

Momail and JAJAH Introduce Innovative Calling Option

Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm

ANTWERP and AALST , Belgium, AHMEDABAD, India and GOTTINGEN, Germany, October 6 /PRNewswire/ -- VIBGYOR Scientific Research, genae associates, Cardiovascular Center Aalst and J.B. Dahm, MD have reached an agreement to form a Core Laboratories joint venture, called imaeon.

imaeon initially will focus on the performance of medical images analysis for clinical research projects, including but not limited to: quantitative coronary and peripheral angiography (QCA, QVA), computed tomography (CT) angiography, intravascular ultrasound (IVUS) and IVUS related techniques, multiple gated acquisition scan (MUGA), optical coherence tomography (OCT), magnetic resonance imaging (MRI), multi slice computer tomography (MSCT), electrocardiogram (ECG) and ECHO assessments.

While meeting or exceeding all quality standards in a timely and cost-effective manner, imaeon will offer expert evaluations of medical images from multi-modality environments and unsurpassed quality clinical research services. It will operate from the main facilities and offices in Ahmedabad, India and from the subsidiary in Antwerp, Belgium and focus on the pharmaceutical, biomedical and medical device industries.

About Cardiovasculair Onderzoek Aalst CVBA

Cardiovasculair Onderzoek Aalst, with principal offices in Aalst, Belgium, provides consultancy assignments and logistics support related to scientific research and scientific studies for physicians, hospitals, universities, pharmaceutical institutions, governments and governmental institutions.

Contact

Paul Nellens, MD - paul.nellens@olvz-aalst.be

About genae associates nv

genae is a privately held NV/SA with principal offices in Antwerp, Belgium and is ISO 9001:2000 certified for CRO, Core Laboratories and Services Provider for the Medical Industries. These global services include but are not limited to Clinical Data Management, Electronic Data Capture (EDC), Statistical Analysis, Scientific & Medical Writing, CE-Marking (MDD) and Training & Education.

Contact

Bart Segers - +32-475-566-780, bart.segers@genae.com - http://www.genae.com

About VIBGYOR Scientific Research Pvt. Ltd.

VIBGYOR is a leading ISO 9001:2000 Certified Scientific Contract Research Organization with offices in India, USA and UK, providing a broad spectrum of clinical research services such as total project management of phase II-IV drug and device studies, FIM device studies, ECG core lab, Medical Writing and Communication, Regulatory Services, Pharmacovigilance, Pharmacodevicevigilance, Clinical Research Training, IT Services including software and e-CRF development.

Contact

Bina Naik, MD - bina.naik@vibgyorcare.com - http://www.vibgyorcare.com

About J.B. Dahm, MD

Prof. Dahm is Director of the Department of Cardiology & Angiology at the Heart & Vascular Center Neu-Bethlehem in Gottingen, Germany and Director of the Core Laboratories of genae associates nv.

Contact

J.B. Dahm, MD - dahm@herz-gefaesszentrum.org

SOURCE genae associates

International News / Press Release source: PR Newswire
Copyright PR Newswire. All Rights Reserved.

International Business News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Cohen & Steers Funds Quarterly Data Now Available
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Back-to-Back Top 10 Finishes for Indy Racing League Rookie Mario Moraes
PR Newswire

MutualFirst Announces Increased Second Quarter 2008 Earnings
PR Newswire

International Health News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Galderma Announces Approval for Differin(R) Gel 0.1% in Japan
PR Newswire

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
PR Newswire

Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
PR Newswire

Pharmasset Announces $25.9 Million Registered Direct Offering of Common Stock
PR Newswire

International Medical News / Press Releases

/C O R R E C T I O N -- China Sky One Medical, Inc./
PR Newswire

Biopten (Sapropterin Dihydrochloride) Approved by Japanese Ministry of Health for the Treatment of PKU
PR Newswire

Huifeng Bio-pharmaceutical Technology Inc. Announces Strategic Alliance with Premier Media Service Inc.
PR Newswire

Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
PR Newswire

Genesis Pharmaceuticals Announces SFDA Approval for Radix Isatidis Dispersible Tablets
PR Newswire